What is Corebridge Financial Inc's earnings per share (EPS)?

Corebridge Financial Inc (CRBG) reported diluted earnings per share of -$0.68 for fiscal year 2025. This represents a -118.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Corebridge Financial Inc (CRBG) Financials

CRBG

Trailing 12 months to June 30, 2026

Revenue $20.1B +29.8% YoY

Net Income $907.0M +369.1% YoY

EPS (Diluted) $1.59 +301.3% YoY

Operating Cash Flow $1.9B +10.4% YoY

Market Cap $15.1B as of Sep 10, 2026

Price / Sales 0.8x on $20.1B revenue, trailing 12 months to June 30, 2026

Price / Earnings 16.6x on $907.0M net income, trailing 12 months to June 30, 2026

Price / Book 1.4x on $10.7B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CRBG SEC filings page.

Corebridge Financial Inc (CRBG) reported $20.1B in revenue over the twelve months to Jun 30, 2026, up 29.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CRBG FY2025 2026-08-29

Corebridge’s dominant mechanic is a thin-equity, liability-funded balance sheet whose earnings can diverge sharply from operating cash generation.

FY2025 cash conversion diverged from reported earnings: operating cash flow was $2.0B even as net income was -$366M, so the cash statement and income statement tell different stories. FY2024 showed net income of $2.2B alongside operating cash flow of $2.2B; the latest gap therefore points to a sharp earnings-quality or timing shift rather than a simple change in cash-producing operations.

FY2025 liabilities reached $399.6B against assets of $413.5B, leaving a comparatively thin equity base. Equity was $13.2B, while reported debt-to-equity was 30.3x; together, they make balance-sheet sensitivity more informative than revenue margins.

Cash allocation reshaped the balance sheet: investing outflows were $13.3B and financing inflows were $10.9B in FY2025, meaning operating cash flow was not the whole funding story. The reported share count fell from 556.0M in FY2024 to 481.7M in FY2025, consistent with capital returns reducing the measured share base.

Financial Health Signals

Financial health score not available

Corebridge Financial Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

3/6

Corebridge Financial Inc passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

Corebridge Financial Inc reported a net loss of $366.0M while generating $2.0B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.9B

YoY+43.6%

QoQ-1.3%

Corebridge Financial Inc generated $3.9B in revenue in Q2 2026. This represents an increase of 43.6% from the same quarter a year earlier. Against the prior quarter it is down 1.3%.

Net Income

$2.0M

YoY+100.3%

QoQ+103.8%

Corebridge Financial Inc reported $2.0M in net income in Q2 2026. This represents an increase of 100.3% from the same quarter a year earlier. Against the prior quarter it is up 103.8%.

EPS (Diluted)

-$0.04

YoY+96.7%

QoQ+63.6%

Corebridge Financial Inc earned -$0.04 per diluted share (EPS) in Q2 2026. This represents an increase of 96.7% from the same quarter a year earlier. Against the prior quarter it is up 63.6%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$358.0M

YoY+20.9%

QoQ-5.3%

5Y CAGR-17.2%

Corebridge Financial Inc held $358.0M in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share

$0.25

YoY+4.2%

QoQ0.0%

Corebridge Financial Inc paid $0.25 per share in dividends in Q2 2026. This represents an increase of 4.2% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

446M

YoY-17.2%

QoQ-2.4%

Corebridge Financial Inc had 446M shares outstanding in Q2 2026. This represents a decrease of 17.2% from the same quarter a year earlier. Against the prior quarter it is down 2.4%.

Free Cash Flow

Not reported for Q2 2026.

Margins & Returns

Net Margin

0.1%

YoY+24.3pp

QoQ+1.4pp

Corebridge Financial Inc's net profit margin was 0.1% in Q2 2026, showing the share of revenue converted to profit. This is up 24.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.

Return on Equity

0.0%

YoY+5.4pp

QoQ+0.5pp

Corebridge Financial Inc's ROE was 0.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 5.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$300.0M

YoY-3.5%

QoQ-76.0%

Corebridge Financial Inc spent $300.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 3.5% from the same quarter a year earlier. Against the prior quarter it is down 76.0%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

CRBG Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRBG quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Revenue	$20.1B	$18.5B-1.2%	$18.7B-0.5%	$18.8B-23.9%	$24.7B+6.2%	$23.3B+54.4%	$15.1B
SG&A Expenses	$1.9B	$2.0B-0.7%	$2.0B-11.7%	$2.3B-1.8%	$2.3B+10.4%	$2.1B+3.8%	$2.0B
Interest Expense	$529.0M	$552.0M-0.4%	$554.0M-4.5%	$580.0M+8.6%	$534.0M+37.3%	$389.0M-20.6%	$490.0M
Income Tax	$202.0M	-$151.0M-125.2%	$600.0M+725.0%	-$96.0M-104.8%	$2.0B-3.4%	$2.1B+13980.0%	-$15.0M
Net Income	$907.0M	-$366.0M-116.4%	$2.2B+102.0%	$1.1B-86.5%	$8.2B-1.0%	$8.2B+1184.0%	$642.0M
EPS (Basic)	N/A	-$0.68-118.2%	$3.73+116.9%	$1.72-86.4%	$12.63	N/A	N/A
EPS (Diluted)	$1.59	-$0.68-118.3%	$3.72+117.5%	$1.71-86.4%	$12.60	N/A	N/A
Diluted Shares (Avg)	N/A	539M-10.0%	599M-7.1%	645M-0.3%	647M	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$3.9B+43.6%	$4.0B+11.0%	$6.8B+3.1%	$5.4B+108.4%	$2.7B-26.5%	$3.6B-38.8%	$6.6B+100.3%	$2.6B-52.8%
SG&A Expenses	$466.0M-9.9%	$468.0M-11.0%	$478.0M+9.4%	$481.0M+1.3%	$517.0M-2.8%	$526.0M-8.0%	$437.0M-9.9%	$475.0M-22.3%
Interest Expense	$131.0M-4.4%	$131.0M-11.5%	$132.0M-9.0%	$135.0M+1.5%	$137.0M-0.7%	$148.0M+7.2%	$145.0M+4.3%	$133.0M-1.5%
Income Tax	$50.0M-16.7%	$158.0M+177.1%	$173.0M-75.4%	-$179.0M+56.0%	$60.0M-47.8%	-$205.0M-208.5%	$703.0M+262.7%	-$407.0M-203.8%
Net Income	$2.0M+100.3%	-$53.0M+92.0%	$814.0M-62.5%	$144.0M+112.2%	-$660.0M-280.8%	-$664.0M-175.6%	$2.2B+265.9%	-$1.2B-156.4%
EPS (Basic)	-$0.04+96.7%	-$0.11+90.8%	$1.47-59.5%	$0.27+113.4%	-$1.20-300.0%	-$1.19-184.4%	$3.63+280.6%	-$2.02-161.4%
EPS (Diluted)	-$0.04+96.7%	-$0.11+90.8%	$1.47-59.4%	$0.27+113.4%	-$1.20-303.4%	-$1.19-184.4%	$3.62+280.1%	-$2.02-161.6%
Diluted Shares (Avg)	454M-17.5%	474M-15.1%	N/A	541M-7.9%	550M-10.2%	558M-10.7%	N/A	587M-8.4%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

CRBG Balance Sheet

CRBG quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Total Assets	$413.5B+6.2%	$389.4B+2.7%	$379.3B+5.3%	$360.3B-15.3%	$425.4B+0.7%	$422.4B
Cash & Equivalents	$453.0M-45.0%	$824.0M+31.2%	$628.0M-0.8%	$633.0M+5.3%	$601.0M-34.5%	$918.0M
Short-Term Investments	$5.7B+13.9%	$5.0B+14.9%	$4.3B-1.5%	$4.4B-19.6%	$5.5B	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	$117.0M-33.1%	$175.0M-8.9%	$192.0M-11.9%	$218.0M
Total Liabilities	$399.6B+6.0%	$377.1B+2.8%	$366.6B+4.8%	$350.0B-11.7%	$396.4B+3.3%	$383.8B
Long-Term Debt	N/A	N/A	N/A	$7.9B+1742.6%	$427.0M	N/A
Total Equity	$13.2B+15.2%	$11.5B-2.6%	$11.8B+25.4%	$9.4B-65.6%	$27.2B-24.5%	$36.1B
Retained Earnings	$18.4B-4.6%	$19.3B+9.6%	$17.6B-3.5%	$18.2B+66.5%	$10.9B-54.0%	$23.8B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$415.8B+4.2%	$407.1B+4.4%	$413.5B+6.2%	$411.3B+3.0%	$399.2B+4.4%	$390.0B+1.1%	$389.4B+2.7%	$399.4B+12.3%
Cash & Equivalents	$358.0M+20.9%	$378.0M-5.3%	$453.0M-45.0%	$322.0M-41.1%	$296.0M-54.7%	$399.0M-6.3%	$824.0M+31.2%	$547.0M-5.9%
Short-Term Investments	$4.6B+20.4%	$4.7B-24.1%	$5.7B+13.9%	$4.6B-5.2%	$3.8B-23.7%	$6.2B+50.4%	$5.0B+14.9%	$4.9B+3.6%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$404.4B+4.8%	$395.5B+4.9%	$399.6B+6.0%	$397.0B+3.1%	$386.0B+4.1%	$377.2B+1.1%	$377.1B+2.8%	$385.0B+11.2%
Total Equity	$10.7B-13.4%	$10.8B-9.8%	$13.2B+15.2%	$13.5B-0.5%	$12.3B+11.9%	$12.0B+3.5%	$11.5B-2.6%	$13.6B+62.7%
Retained Earnings	$18.1B+2.3%	$18.2B-1.4%	$18.4B-4.6%	$17.7B+2.7%	$17.7B-4.7%	$18.5B+0.8%	$19.3B+9.6%	$17.2B-12.9%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

CRBG Cash Flow Statement

CRBG quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Operating Cash Flow	$1.9B	$2.0B-6.0%	$2.2B-35.9%	$3.4B+28.1%	$2.6B+9.0%	$2.4B-27.7%	$3.3B
Depreciation & Amortization	N/A	$556.0M+188.1%	$193.0M-47.3%	$366.0M-37.4%	$585.0M+41.6%	$413.0M+27.1%	$325.0M
Stock-Based Compensation	N/A	$67.0M+15.5%	$58.0M-3.3%	$60.0M-20.0%	$75.0M-14.8%	$88.0M+18.9%	$74.0M
Investing Cash Flow	-$7.8B	-$13.3B-15.6%	-$11.5B-110.7%	-$5.5B+24.5%	-$7.3B-268.7%	-$2.0B+75.1%	-$7.9B
Financing Cash Flow	$6.0B	$10.9B+14.2%	$9.6B+353.2%	$2.1B-54.8%	$4.7B+720.7%	-$753.0M-116.1%	$4.7B
Dividends Paid	$473.0M	$511.0M-6.1%	$544.0M-68.4%	$1.7B+96.6%	$876.0M	$0	$0
Share Buybacks	$3.0B	$2.1B+18.2%	$1.8B+259.8%	$498.0M	$0	$0	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$44.0M+83.0%	-$9.0M-102.4%	$1.9B+27.2%	$24.0M-71.1%	-$259.0M-2777.8%	$375.0M-37.3%	$1.5B+92.8%	$83.0M-91.8%
Depreciation & Amortization	$173.0M+84.0%	$165.0M+85.4%	$174.0M+185.2%	$199.0M+452.8%	$94.0M+193.8%	$89.0M+39.1%	$61.0M+205.0%	$36.0M-66.4%
Investing Cash Flow	$1.6B+158.6%	-$2.5B+34.6%	-$3.5B-157.2%	-$3.3B+46.7%	-$2.7B-102.6%	-$3.9B-46.4%	-$1.3B+38.9%	-$6.2B-161.8%
Financing Cash Flow	-$1.5B-154.5%	$2.5B-19.7%	$1.7B+1078.1%	$3.3B-45.0%	$2.8B+81.7%	$3.1B+66.7%	$146.0M-90.0%	$6.0B+407.1%
Dividends Paid	$112.0M-14.5%	$114.0M-14.3%	$119.0M-7.8%	$128.0M-3.8%	$131.0M-5.8%	$133.0M-7.0%	$129.0M-85.3%	$133.0M-8.9%
Share Buybacks	$300.0M-3.5%	$1.3B+289.4%	$1.1B+177.9%	$380.0M-46.9%	$311.0M-28.7%	$321.0M+32.1%	$398.0M+57.9%	$715.0M+1454.3%

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow.

CRBG Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRBG quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Net Margin	-2.0%-13.9pp	11.9%+6.0pp	5.9%-27.2pp	33.0%-2.4pp	35.4%+31.2pp	4.3%
Return on Equity	-2.8%-22.2pp	19.5%+10.1pp	9.4%-77.6pp	87.0%+56.7pp	30.3%+28.5pp	1.8%
Return on Assets	-0.1%-0.7pp	0.6%+0.3pp	0.3%-2.0pp	2.3%+0.3pp	1.9%+1.8pp	0.1%
Debt-to-Equity	30.27-2.6x	32.90+1.7x	31.16+30.3x	0.84+0.8x	0.02-10.6x	10.64
Asset Turnover	0.040.0x	0.050.0x	0.050.0x	0.070.0x	0.050.0x	0.04

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	0.1%+24.3pp	-1.3%+17.3pp	12.0%-21.0pp	2.7%+48.2pp	-24.2%-34.1pp	-18.6%-33.6pp	33.1%+73.0pp	-45.6%-83.7pp
Return on Equity	0.0%+5.4pp	-0.5%+5.0pp	6.2%-12.8pp	1.1%+9.8pp	-5.4%-8.7pp	-5.5%-13.1pp	18.9%+30.1pp	-8.7%-33.8pp
Return on Assets	0.0%+0.2pp	0.0%+0.2pp	0.2%-0.4pp	0.0%+0.3pp	-0.2%-0.3pp	-0.2%-0.4pp	0.6%+0.9pp	-0.3%-0.9pp
Debt-to-Equity	37.97+6.6x	36.61+5.1x	30.27-2.6x	29.31+1.0x	31.38-2.3x	31.48-0.8x	32.90+1.7x	28.29-13.1x
Asset Turnover	0.010.0x	0.010.0x	0.020.0x	0.010.0x	0.010.0x	0.010.0x	0.020.0x	0.010.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Corebridge Financial Inc CRBG	FY2025	$18.5B	-$366.0M	-2.0%	$15.1B	—
Principal Financial PFG	FY2025	$15.6B	$1.3B	8.0%	$24.4B	21/100
Equitable Holdings Inc EQH	FY2025	$11.7B	-$1K	0.0%	$14.2B	13/100
TPG INC TPG	FY2025	$4.7B	$184.6M	4.0%	$8.2B	26/100
Ares Capital ARCC	FY2025	N/A	$1.3B	N/A	$14.1B	—
T Rowe Price Grp TROW	FY2025	$7.3B	$2.1B	28.5%	$23.0B	51/100

Where Corebridge Financial Inc Ranks

Frequently Asked Questions

What is Corebridge Financial Inc's annual revenue?

Corebridge Financial Inc (CRBG) reported $18.5B in total revenue for fiscal year 2025. This represents a -1.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Corebridge Financial Inc's revenue growing?

Corebridge Financial Inc (CRBG) revenue declined by 1.2% year-over-year, from $18.7B to $18.5B in fiscal year 2025.

Is Corebridge Financial Inc profitable?

No, Corebridge Financial Inc (CRBG) reported a net income of -$366.0M in fiscal year 2025, with a net profit margin of -2.0%.

What is Corebridge Financial Inc's net profit margin?

Corebridge Financial Inc (CRBG) had a net profit margin of -2.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Corebridge Financial Inc's return on equity (ROE)?

Corebridge Financial Inc (CRBG) has a return on equity of -2.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Corebridge Financial Inc's operating cash flow?

Corebridge Financial Inc (CRBG) generated $2.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Corebridge Financial Inc's total assets?

Corebridge Financial Inc (CRBG) had $413.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Corebridge Financial Inc buy back shares?

Yes, Corebridge Financial Inc (CRBG) spent $2.1B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Corebridge Financial Inc have outstanding?

Corebridge Financial Inc (CRBG) had 482M shares outstanding as of fiscal year 2025.

What is Corebridge Financial Inc's debt-to-equity ratio?

Corebridge Financial Inc (CRBG) had a debt-to-equity ratio of 30.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Corebridge Financial Inc's return on assets (ROA)?

Corebridge Financial Inc (CRBG) had a return on assets of -0.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Corebridge Financial Inc's P/E ratio?

Corebridge Financial Inc (CRBG) trades at 16.6x earnings, its market capitalization divided by net income of $907.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $15.1B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Corebridge Financial Inc's price-to-sales ratio?

Corebridge Financial Inc (CRBG) trades at 0.8x sales, its market capitalization divided by revenue of $20.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $15.1B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Corebridge Financial Inc's Piotroski F-Score?

Corebridge Financial Inc (CRBG) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Corebridge Financial Inc's earnings high quality?

Corebridge Financial Inc (CRBG) reported a net loss of $366.0M while generating $2.0B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.